YMR147W Antibody

What is YMR147W and why would researchers need antibodies against it?

YMR147W (also designated as LDO45) is a gene found in the budding yeast Saccharomyces cerevisiae . The protein encoded by this gene is involved in cellular processes that researchers may wish to study through immunological techniques. Antibodies against this protein allow for detection, localization, and functional studies of the YMR147W-encoded protein in yeast cellular contexts. These antibodies serve as valuable tools for understanding protein expression patterns, protein-protein interactions, and the role of YMR147W in various cellular pathways within yeast systems . Similar to approaches used with other proteins, antibodies against YMR147W can be employed in techniques such as Western blotting, immunoprecipitation, and immunofluorescence to elucidate its biological functions.

What expression systems are most effective for producing YMR147W antigens for antibody development?

For producing YMR147W antigens, E. coli-based expression systems are often most effective for initial antibody development. The procedure involves:

• Cloning the YMR147W gene or specific epitope regions into an appropriate expression vector (e.g., pET series)

• Transforming competent E. coli cells using calcium chloride methods as described in standard protocols

• Inducing protein expression under optimized conditions (temperature, IPTG concentration)

• Purifying the recombinant protein using affinity chromatography methods

For more native protein conformation, yeast expression systems may be preferable, particularly for antibodies targeting conformational epitopes. When working with S. cerevisiae expression systems, transformation protocols using lithium acetate methods are generally more appropriate than the calcium chloride methods used for E. coli . Selection of the expression system should be guided by the intended antibody application, with bacterial systems typically yielding higher protein quantities but potentially lacking post-translational modifications found in the native yeast protein.

How do I validate the specificity of a newly developed YMR147W antibody?

Validating specificity of a YMR147W antibody requires a multi-faceted approach:

• Western blot with controls: Compare wild-type yeast lysates with YMR147W knockout strains. A specific antibody will detect bands at the expected molecular weight in wild-type samples but show no signal in knockout samples, similar to the validation approach demonstrated for other proteins .

• Preabsorption tests: Preincubate the antibody with purified YMR147W protein before immunodetection. Specific antibodies will show diminished or absent signal after preabsorption.

• Cross-reactivity assessment: Test the antibody against lysates from related yeast species to evaluate potential cross-reactivity with homologous proteins.

• Immunoprecipitation validation: Verify that the antibody can specifically precipitate YMR147W protein from yeast lysates, with confirmation by mass spectrometry.

For rigorous validation, Western blot analysis should be performed under both reducing and non-reducing conditions, as demonstrated in the protocols for other protein antibodies . This allows assessment of whether the antibody recognizes linear or conformational epitopes.

What epitope selection strategies maximize YMR147W antibody specificity?

For optimal YMR147W antibody specificity, epitope selection should consider:

• Sequence uniqueness analysis: Compare YMR147W protein sequence against the entire S. cerevisiae proteome to identify regions with minimal homology to other proteins. Bioinformatic tools like BLAST should be employed to identify unique regions of at least 10-15 amino acids.

• Structural accessibility: Select epitopes likely exposed on the protein surface based on hydrophilicity plots and secondary structure predictions.

• Evolutionary conservation assessment: For species-specific antibodies, target regions with low conservation; for broadly reactive antibodies, select highly conserved epitopes.

• Post-translational modification avoidance: Avoid regions containing known or predicted PTM sites unless those modifications are specifically of interest.

• Multiple epitope approach: Develop antibodies against different regions of YMR147W to provide complementary tools for validation and different applications.

Careful epitope selection significantly impacts downstream applications, as demonstrated in antibody development for other target proteins . Synthetic peptide antigens representing carefully selected epitopes often yield more specific antibodies than those raised against full-length proteins, which may recognize conserved domains present in related proteins.

How can I optimize Western blot protocols specifically for YMR147W detection?

Optimizing Western blot protocols for YMR147W detection requires several technical considerations:

• Sample preparation: Yeast cell lysis requires more rigorous methods than mammalian cells. Effective lysis can be achieved using:

  • Glass bead disruption in appropriate buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, protease inhibitors)

  • Flash freezing in liquid nitrogen followed by mechanical disruption

• Gel conditions: For optimal resolution of YMR147W protein:

  • Use 10-12% polyacrylamide gels for standard SDS-PAGE

  • Consider gradient gels (4-15%) if detecting multiple protein forms

  • Run gels at lower voltage (80-100V) for better resolution

• Transfer parameters:

  • Semi-dry transfer: 15V for 30-45 minutes

  • Wet transfer: 30V overnight at 4°C in transfer buffer containing 20% methanol

• Blocking optimization:

  • Test both BSA (3-5%) and non-fat dry milk (5%) in TBS-T to determine optimal blocking agent

  • Block for 1-2 hours at room temperature or overnight at 4°C

• Antibody dilution and incubation:

  • Start with 1:1000 dilution for primary antibody

  • Incubate overnight at 4°C with gentle agitation

  • Secondary antibody typically used at 1:5000-1:10000 dilution

• Detection system:

  • HRP-conjugated secondary antibodies with enhanced chemiluminescence provide good sensitivity

  • For lower abundance proteins, consider using more sensitive substrates or fluorescent secondary antibodies

Following protocols similar to those used for human protein detection but adapted for yeast samples will improve detection sensitivity and specificity.

What are the most effective immunoprecipitation strategies for studying YMR147W protein interactions?

For studying YMR147W protein interactions through immunoprecipitation:

• Crosslinking approach:

  • Apply in vivo crosslinking with formaldehyde (1%) for 10-15 minutes before cell lysis

  • This preserves transient protein interactions

  • Reverse crosslinks after immunoprecipitation using heat treatment (65°C for 6-12 hours)

• Lysis buffer optimization:

  • Test different detergent concentrations (0.1-1% NP-40 or Triton X-100)

  • Include salt concentrations (150-300 mM NaCl) to balance specificity and yield

  • Always include protease inhibitors and phosphatase inhibitors if phosphorylation is relevant

• Antibody coupling strategies:

  • Direct coupling to protein A/G beads reduces antibody contamination in mass spectrometry analysis

  • Covalent coupling using dimethyl pimelimidate provides stable antibody attachment

  • Commercial kits are available for reproducible coupling

• Elution methods:

  • Gentle elution with antibody-specific epitope peptides (when available)

  • pH-based elution (glycine buffer pH 2.5) followed by immediate neutralization

  • SDS elution for mass spectrometry applications

• Controls:

  • IgG isotype control antibodies

  • Immunoprecipitation from YMR147W knockout strains

  • Preblocking antibody with purified antigen

These approaches are similar to standard immunoprecipitation protocols but adapted specifically for yeast proteins and cellular environments .

How do monoclonal and polyclonal antibodies compare for YMR147W research applications?

Comparing monoclonal versus polyclonal antibodies for YMR147W research:

What approaches can address cross-reactivity challenges with YMR147W antibodies in multi-protein complexes?

To address cross-reactivity challenges when studying YMR147W in protein complexes:

• Affinity purification strategies:

  • Implement two-step purification using epitope-tagged YMR147W expressed in yeast

  • First purify using tag-specific antibodies, then with YMR147W-specific antibody

  • This sequential approach significantly reduces non-specific binding

• Competitive binding assays:

  • Perform immunoprecipitation in the presence of increasing amounts of purified YMR147W protein

  • Specific interactions will show dose-dependent reduction, while non-specific binding remains

• Depletion approach:

  • Pre-clear lysates with antibodies against known cross-reactive proteins

  • Follow with YMR147W immunoprecipitation to isolate specific complexes

• Validation with orthogonal methods:

  • Confirm protein interactions identified by IP through alternative methods such as yeast two-hybrid assays

  • Compare interaction profiles before and after specific knockdowns

• Mass spectrometry analysis:

  • Use quantitative proteomics approaches (SILAC, TMT labeling) to distinguish true interactors from background

  • Compare IP results from wild-type and YMR147W knockout strains to identify specific binding partners

Implementing these approaches helps distinguish between specific and non-specific interactions, providing more confidence in protein complex identification .

How can YMR147W antibodies be effectively used in chromatin immunoprecipitation (ChIP) experiments?

For effective ChIP experiments using YMR147W antibodies:

• Crosslinking optimization:

  • Test different formaldehyde concentrations (0.75-1.5%) and crosslinking times (10-20 minutes)

  • For protein-protein interactions, consider dual crosslinking with DSG (disuccinimidyl glutarate) before formaldehyde

• Chromatin fragmentation:

  • Optimize sonication conditions to achieve fragments of 200-500 bp

  • Verify fragmentation efficiency by agarose gel electrophoresis

  • Consider enzymatic fragmentation (MNase digestion) as an alternative approach

• Antibody selection and validation:

  • Verify antibody specificity for ChIP by performing IP followed by Western blot

  • Test antibody performance in ChIP using positive and negative control regions

  • Consider using epitope-tagged YMR147W if antibody performance is suboptimal

• Protocol modifications for yeast cells:

  • Implement spheroplasting with zymolyase treatment before crosslinking

  • Use glass bead disruption for efficient cell lysis

  • Include fungal protease inhibitors in all buffers

• Controls and normalization:

  • Include input chromatin, IgG control, and YMR147W knockout samples

  • Normalize ChIP-qPCR data to input and reference genes

  • For ChIP-seq, include spike-in controls for normalization between samples

• Analysis of YMR147W binding sites:

  • Perform ChIP-qPCR for candidate binding sites

  • For genome-wide analysis, proceed with ChIP-seq

  • Analyze data using peak calling algorithms appropriate for transcription factors or chromatin modifiers

These approaches allow for investigation of YMR147W association with chromatin, which may provide insights into potential roles in transcriptional regulation or chromatin organization .

What are the main causes of false positives in YMR147W antibody applications and how can they be minimized?

The main causes of false positives in YMR147W antibody applications include:

• Cross-reactivity with related proteins:

  • Solution: Pre-adsorb antibody with recombinant proteins of related family members

  • Validate using knockout controls as demonstrated in other antibody systems

  • Perform immunoprecipitation followed by mass spectrometry to identify all bound proteins

• Non-specific binding to protein A/G:

  • Solution: Use pre-clearing steps with protein A/G beads alone before adding specific antibody

  • Include appropriate isotype control antibodies in parallel experiments

  • Consider using alternative binding proteins like recombinant protein A/G fusion proteins

• Post-translational modifications altering epitope recognition:

  • Solution: Use phosphatase or glycosidase treatments to determine if modifications affect binding

  • Develop antibodies against specific modified forms if modifications are important

  • Employ multiple antibodies recognizing different epitopes of YMR147W

• Buffer components causing aggregation:

  • Solution: Test different detergents and salt concentrations

  • Include reducing agents like DTT (1-5 mM) to prevent disulfide-mediated aggregation

  • Filter buffers before use to remove particulates that may bind antibodies non-specifically

• Inadequate blocking:

  • Solution: Optimize blocking conditions (agent, concentration, time)

  • Test different blocking agents (BSA, milk, commercial blocking solutions)

  • Increase blocking stringency by adding 0.1-0.5% Tween-20 or 0.1% Triton X-100

Implementing these strategies will significantly reduce false positives and increase confidence in experimental results, similar to approaches used in other antibody validation systems .

How can I quantitatively analyze YMR147W expression levels in different yeast strains or conditions?

For quantitative analysis of YMR147W expression across different conditions:

• Western blot quantification:

  • Use internal loading controls (e.g., actin, GAPDH) for normalization

  • Implement standard curves with recombinant YMR147W protein

  • Use fluorescent secondary antibodies for wider linear detection range

  • Analyze band intensity using software such as ImageJ or commercial alternatives

• ELISA development:

  • Develop sandwich ELISA using capture and detection antibodies against different YMR147W epitopes

  • Generate standard curves with purified recombinant YMR147W

  • Optimize sample preparation to ensure consistent protein extraction

  • Consider using automated ELISA systems for higher throughput

• Flow cytometry analysis:

  • Fix and permeabilize yeast cells for intracellular staining

  • Use fluorophore-conjugated primary antibodies or appropriate secondary antibodies

  • Include proper isotype controls

  • Gate on single cells and analyze mean fluorescence intensity

• Mass spectrometry-based quantification:

  • Implement targeted proteomics approaches (SRM/MRM)

  • Use isotopically labeled peptide standards for absolute quantification

  • Select proteotypic peptides specific to YMR147W

  • Analyze data using specialized software for peptide quantification

• RT-qPCR for transcript analysis:

  • Design specific primers for YMR147W

  • Normalize to stable reference genes

  • Validate primers for efficiency and specificity

  • Compare transcript levels with protein levels to assess post-transcriptional regulation

These methodologies provide complementary approaches to quantify YMR147W expression, with each offering different advantages in terms of sensitivity, throughput, and information content .

What are the most sensitive methods for detecting low-abundance YMR147W protein in yeast extracts?

For detecting low-abundance YMR147W protein:

• Enhanced chemiluminescence (ECL) Western blotting:

  • Use high-sensitivity ECL substrates (e.g., SuperSignal West Femto)

  • Optimize antibody concentration and incubation conditions

  • Extend exposure times with low-noise imaging systems

  • Consider using signal enhancement systems (biotin-streptavidin amplification)

• Immunoprecipitation before Western blotting:

  • Concentrate YMR147W protein from large sample volumes

  • Use optimized IP conditions as discussed previously

  • Elute in minimal volume to maximize concentration for detection

• Proximity ligation assay (PLA):

  • Use two antibodies recognizing different YMR147W epitopes

  • Secondary antibodies with attached oligonucleotides generate amplifiable signal

  • Each protein molecule can generate multiple signal spots

  • Provides single-molecule sensitivity with spatial information

• Single-molecule array (Simoa) technology:

  • Capture YMR147W on paramagnetic beads

  • Detect with enzyme-labeled detection antibodies

  • Isolate individual beads in femtoliter-sized wells

  • Digital counting of positive wells enables extremely sensitive detection

• Mass spectrometry with targeted approaches:

  • Implement parallel reaction monitoring (PRM) or selected reaction monitoring (SRM)

  • Focus instrument time on YMR147W-specific peptides

  • Use internal standard peptides for absolute quantification

  • Consider sample fractionation to reduce matrix complexity

These highly sensitive methods can detect proteins at sub-nanogram levels, allowing for analysis of low-abundance proteins like YMR147W in complex yeast extracts .

How can YMR147W antibodies be applied in high-throughput screening applications?

For high-throughput screening with YMR147W antibodies:

• Automated immunofluorescence microscopy:

  • Develop protocols for fixed yeast cells in 96/384-well formats

  • Implement automated image acquisition and analysis

  • Quantify YMR147W localization changes in response to genetic or chemical perturbations

  • Validate hits with orthogonal assays

• Reverse phase protein arrays (RPPA):

  • Spot lysates from multiple yeast strains or conditions on nitrocellulose-coated slides

  • Probe with YMR147W antibodies

  • Quantify signal intensity across hundreds of samples simultaneously

  • Normalize to total protein levels

• Bead-based multiplex assays:

  • Couple YMR147W antibodies to spectrally distinct microspheres

  • Analyze multiple proteins simultaneously from the same sample

  • Implement on flow cytometry platforms for high-throughput detection

  • Include appropriate controls for specificity validation

• Protein microarrays for interaction screening:

  • Use purified YMR147W protein to probe arrays containing thousands of potential interacting proteins

  • Alternatively, use YMR147W antibodies to detect binding of tagged YMR147W to protein arrays

  • Identify novel interaction partners for functional characterization

• Cell-based reporter assays:

  • Generate yeast strains with reporters linked to YMR147W function

  • Screen chemical or genetic libraries for modulators

  • Use antibodies to validate mechanism of action for identified modulators

These approaches enable systematic analysis of YMR147W function across diverse conditions, facilitating discovery of regulatory mechanisms and interaction networks .

What are the current technical limitations in YMR147W antibody research and emerging solutions?

Current technical limitations and emerging solutions in YMR147W antibody research:

These emerging technologies address specific limitations in current antibody-based research approaches and may significantly enhance our ability to study YMR147W protein dynamics and functions in complex cellular contexts .

How can computational approaches improve YMR147W antibody design and application?

Computational approaches to enhance YMR147W antibody research:

• Epitope prediction algorithms:

  • Implement machine learning models trained on antibody-antigen crystal structures

  • Predict both linear and conformational epitopes with higher accuracy

  • Rank epitopes by predicted immunogenicity and specificity

  • Guide rational antibody design by focusing on optimal epitopes

• Antibody structure modeling:

  • Predict antibody paratope structure using homology modeling

  • Simulate antibody-antigen docking to evaluate binding potential

  • Guide affinity maturation by predicting beneficial mutations

  • Design antibodies with optimized properties for specific applications

• Cross-reactivity prediction:

  • Scan proteome databases for potential cross-reactive proteins

  • Calculate binding energies for primary target versus potential cross-reactants

  • Identify sequence modifications to enhance specificity

  • Predict optimal validation experiments based on potential cross-reactivity

• Analysis pipeline optimization:

  • Develop automated image analysis for immunofluorescence data

  • Implement machine learning for Western blot quantification

  • Create standardized data processing workflows for reproducibility

  • Integrate data from multiple antibody-based techniques

• Systems biology integration:

  • Contextualize YMR147W antibody data within protein interaction networks

  • Predict functional consequences of observed expression changes

  • Model cellular responses to perturbations affecting YMR147W

  • Guide experimental design through in silico hypothesis testing

These computational approaches significantly enhance both the design and application of YMR147W antibodies, improving specificity, sensitivity, and the biological interpretability of experimental results .